{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:33Z","timestamp":1787020653004,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Structured and genome-wide clinical database of thymoma, Nanjing Drum Tower Hospital","award":["(No.2024-LCYJ-DBZ-04)"],"award-info":[{"award-number":["(No.2024-LCYJ-DBZ-04)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02984-2","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:16:26Z","timestamp":1763547386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Elevated triglyceride-glucose index and risk of thymoma-associated myasthenia gravis: a prospective analysis from the UK Biobank"],"prefix":"10.1186","volume":"24","author":[{"given":"Kangle","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"6","key":"2984_CR1","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.21037\/tlcr-20-1222","volume":"10","author":"JC Benitez","year":"2021","unstructured":"Benitez JC, Besse B. Narrative review of immunotherapy in thymic malignancies. Transl Lung Cancer Res. 2021;10(6):3001\u201313.","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"2984_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","volume":"21","author":"AR Punga","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, et al. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21(2):176\u201388.","journal-title":"Lancet Neurol"},{"issue":"1","key":"2984_CR3","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/JS9.0000000000001981","volume":"111","author":"Y Ao","year":"2025","unstructured":"Ao Y, Jiang J, Miao J, et al. A new pragmatic classification system for thymoma-associated myasthenia gravis: a retrospective cohort study. Int J Surg. 2025;111(1):1521\u20135.","journal-title":"Int J Surg"},{"issue":"6","key":"2984_CR4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/mus.27220","volume":"63","author":"D Menon","year":"2021","unstructured":"Menon D, Katzberg H, Barnett C, et al. Thymoma pathology and myasthenia gravis outcomes. Muscle Nerve. 2021;63(6):868\u201373.","journal-title":"Muscle Nerve"},{"issue":"1","key":"2984_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","volume":"19","author":"C Nelke","year":"2022","unstructured":"Nelke C, Stascheit F, Eckert C, et al. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. J Neuroinflammation. 2022;19(1):89.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"2984_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jtho.2025.04.014","volume":"20","author":"S Wang","year":"2025","unstructured":"Wang S, Zhu M, Dong J, et al. Perioperative safety and efficacy of efgartigimod for thymoma-associated myasthenia gravis: a prospective, multicenter, phase II clinical trial. J Thorac Oncol. 2025;20(8):1120\u201330.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2984_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3945\/an.115.010207","volume":"7","author":"CJ Andersen","year":"2016","unstructured":"Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66\u201375.","journal-title":"Adv Nutr"},{"issue":"1","key":"2984_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1\u20134.","journal-title":"J Clin Invest"},{"issue":"1","key":"2984_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL BOULANG\u00e9","year":"2016","unstructured":"BOULANG\u00e9 CL, Neves AL, Chilloux J, et al. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8(1):42.","journal-title":"Genome Med"},{"issue":"4","key":"2984_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.tem.2020.12.001","volume":"32","author":"A Rehman","year":"2021","unstructured":"Rehman A, Pacher P, HASK\u00f3 G. Role of macrophages in the endocrine system. Trends Endocrinol Metab. 2021;32(4):238\u201356.","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"2984_CR11","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1161\/ATVBAHA.124.319983","volume":"44","author":"MJ Wilkinson","year":"2024","unstructured":"Wilkinson MJ, Shapiro MD. Immune-mediated inflammatory diseases, dyslipidemia, and cardiovascular risk: a complex interplay. Arterioscler Thromb Vasc Biol. 2024;44(12):2396\u2013406.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2984_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","volume":"19","author":"J Alizargar","year":"2020","unstructured":"Alizargar J, Bai CH, Hsieh NC, et al. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","volume":"22","author":"B Che","year":"2023","unstructured":"Che B, Zhong C, Zhang R, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12933-023-02055-4","volume":"22","author":"C Cui","year":"2023","unstructured":"Cui C, Liu L, Zhang T, et al. Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2023;22(1):325.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-022-01732-0","volume":"22","author":"Y Yang","year":"2023","unstructured":"Yang Y, Huang X, Wang Y, et al. The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):2.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-023-01973-7","volume":"22","author":"A Khalaji","year":"2023","unstructured":"Khalaji A, Behnoush AH, Khanmohammadi S, et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):244.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12933-024-02392-y","volume":"23","author":"SS Nayak","year":"2024","unstructured":"Nayak SS, Kuriyakose D, Polisetty LD, et al. Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis. Cardiovasc Diabetol. 2024;23(1):310.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12933-022-01658-7","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Chan JSK, Guan B, et al. Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a mendelian randomization analysis. Cardiovasc Diabetol. 2022;21(1):229.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12933-024-02385-x","volume":"23","author":"C Tian","year":"2024","unstructured":"Tian C, Chen Y, Xu B, et al. Association of triglyceride-glucose index with the risk of incident aortic dissection and aneurysm: a large-scale prospective cohort study in UK Biobank. Cardiovasc Diabetol. 2024;23(1):282.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2984_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.nmd.2023.01.007","volume":"33","author":"A Mevius","year":"2023","unstructured":"Mevius A, J\u00f6res L, Biskup J, Maywald U, Lehnerer S, Meisel A. Epidemiology and treatment of myasthenia gravis: a retrospective study using a large insurance claims dataset in Germany. Neuromuscul Disord. 2023;33(4):324\u201333. https:\/\/doi.org\/10.1016\/j.nmd.2023.01.007.","journal-title":"Neuromuscul Disord"},{"key":"2984_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/imm3.70001","author":"X Ke","year":"2025","unstructured":"Ke X, Li K, Lin A, et al. FastUKB: a revolutionary tool for simplifying UK Biobank data analysis. iMetaMed. 2025. https:\/\/doi.org\/10.1002\/imm3.70001.","journal-title":"iMetaMed"},{"issue":"1","key":"2984_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-023-01893-6","volume":"22","author":"T Chen","year":"2023","unstructured":"Chen T, Qian Y, Deng X. Triglyceride glucose index is a significant predictor of severe disturbance of consciousness and all-cause mortality in critical cerebrovascular disease patients. Cardiovasc Diabetol. 2023;22(1):156.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12889-024-18272-9","volume":"24","author":"J Huang","year":"2024","unstructured":"Huang J, Rozi R, Ma J, et al. Association between higher triglyceride glucose index and increased risk of osteoarthritis: data from NHANES 2015\u20132020. BMC Public Health. 2024;24(1):758.","journal-title":"BMC Public Health"},{"issue":"1","key":"2984_CR26","doi-asserted-by":"publisher","first-page":"17778","DOI":"10.1038\/s41598-024-68841-6","volume":"14","author":"H Li","year":"2024","unstructured":"Li H, Zhang C. Association between triglyceride-glucose index and gallstones: a cross-sectional study. Sci Rep. 2024;14(1):17778.","journal-title":"Sci Rep"},{"issue":"1","key":"2984_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, et al. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12933-023-01870-z","volume":"22","author":"Y Wu","year":"2023","unstructured":"Wu Y, Yang Y, Zhang J, et al. The change of triglyceride-glucose index may predict incidence of stroke in the general population over 45 years old. Cardiovasc Diabetol. 2023;22(1):132.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12933-023-02002-3","volume":"22","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Chen S, Lin C, et al. Association of triglyceride-glucose index trajectory and frailty in urban older residents: evidence from the 10-year follow-up in a cohort study. Cardiovasc Diabetol. 2023;22(1):264.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02209-y","volume":"23","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Gu Y, Zhang B. Associations of triglyceride-glucose (TyG) index with chest pain incidence and mortality among the U.S. population. Cardiovasc Diabetol. 2024;23(1):111.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2984_CR31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","volume":"32","author":"DH Son","year":"2022","unstructured":"Son DH, Lee HS, Lee YJ, Lee JH, Han JH. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2022;32(3):596\u2013604. https:\/\/doi.org\/10.1016\/j.numecd.2021.11.017.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"2984_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.15747\/ACNM.2024.16.3.168","volume":"16","author":"MS Park","year":"2024","unstructured":"Park MS. Triglyceride-glucose index predicts future metabolic syndrome in an adult population, Korea: a prospective cohort study. Ann Clin Nutr Metab. 2024;16(3):168\u201372. https:\/\/doi.org\/10.15747\/ACNM.2024.16.3.168.","journal-title":"Ann Clin Nutr Metab"},{"issue":"3","key":"2984_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, Demarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144\u201353.","journal-title":"Nat Rev Endocrinol"},{"key":"2984_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","volume":"148","author":"V Rani","year":"2016","unstructured":"Rani V, Deep G, Singh RK, et al. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183\u201393.","journal-title":"Life Sci"},{"key":"2984_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.phrs.2018.01.009","volume":"133","author":"G Medina","year":"2018","unstructured":"Medina G, Vera-Lastra O, Peralta-Amaro AL, et al. Metabolic syndrome, autoimmunity and rheumatic diseases. Pharmacol Res. 2018;133:277\u201388.","journal-title":"Pharmacol Res"},{"key":"2984_CR36","doi-asserted-by":"publisher","first-page":"103318","DOI":"10.1016\/j.jaut.2024.103318","volume":"149","author":"S H\u00e4ssler","year":"2024","unstructured":"H\u00e4ssler S, Lorenzon R, Binvignat M, et al. Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases. J Autoimmun. 2024;149:103318.","journal-title":"J Autoimmun"},{"issue":"1","key":"2984_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-022-01729-9","volume":"21","author":"X Tian","year":"2022","unstructured":"Tian X, Chen S, Wang P, et al. Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):289.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2984_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12933-024-02158-6","volume":"23","author":"Z Wang","year":"2024","unstructured":"Wang Z, He H, Xie Y, et al. Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study. Cardiovasc Diabetol. 2024;23(1):87.","journal-title":"Cardiovasc Diabetol"},{"key":"2984_CR39","doi-asserted-by":"publisher","first-page":"1416634","DOI":"10.3389\/fendo.2024.1416634","volume":"15","author":"C Cao","year":"2024","unstructured":"Cao C, Hu H, Xiao P, Zan Y, Chang X, Han Y, et al. Nonlinear relationship between triglyceride-glucose index and the risk of prediabetes and diabetes: a secondary retrospective cohort study. Front Endocrinol (Lausanne). 2024;15:1416634. https:\/\/doi.org\/10.3389\/fendo.2024.1416634.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2984_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40101-024-00355-6","volume":"43","author":"B Kim","year":"2024","unstructured":"Kim B, Taniguchi K, Isobe T, et al. Triglyceride-glucose index is capable of identifying metabolically obese, normal-weight older individuals. J Physiol Anthropol. 2024;43:8. https:\/\/doi.org\/10.1186\/s40101-024-00355-6.","journal-title":"J Physiol Anthropol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02984-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:16:27Z","timestamp":1763547387000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02984-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2984"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02984-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The UK Biobank was established following ethical approval from the North West Multi-Centre Research Ethics Committee (REC reference: 11\/NW\/03820). All participants provided written informed consent prior to enrolment. The present analyses were conducted under UK Biobank Application Number 859563, in strict accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}